Y-27632 Dihydrochloride: Selective ROCK Inhibitor for Cytoskeletal and Cancer Research

Executive Summary: Y-27632 dihydrochloride is a potent, cell-permeable inhibitor of Rho-associated protein kinases ROCK1 and ROCK2, exhibiting IC₅₀ values of approximately 140 nM and Ki of 300 nM, respectively, with >200-fold selectivity over other kinases (APExBIO). The compound is widely adopted for studies of Rho/ROCK signaling, cytoskeletal dynamics, stem cell viability, and inhibition of tumor invasion (Liu et al. 2021). In vitro and in vivo evidence demonstrates robust suppression of stress fiber formation and tumor cell invasiveness. Y-27632 is highly soluble in DMSO (≥111.2 mg/mL), ethanol (≥17.57 mg/mL), and water (≥52.9 mg/mL), enabling flexible laboratory workflows. The reagent is a reference standard for dissecting cytoskeletal and oncogenic pathways in translational research (G-418Sulfate.com).

Biological Rationale

Rho-associated protein kinases (ROCK1 and ROCK2) are serine/threonine kinases that mediate RhoA-dependent regulation of the actin cytoskeleton. The Rho/ROCK signaling pathway governs cellular processes such as stress fiber formation, cytokinesis, cell cycle progression, and migration (Liu et al. 2021). Aberrant ROCK signaling is implicated in cancer progression, tissue fibrosis, and neurodegeneration. Selective inhibition of ROCK kinases is a validated strategy for modulating cell morphology, stem cell viability, and tumor invasion (Trametinib.net). Compared to upstream Rho inhibitors, ROCK inhibitors like Y-27632 provide greater specificity and actionable pharmacological control (AP1903.com).

Mechanism of Action of Y-27632 dihydrochloride

Y-27632 dihydrochloride is a small-molecule inhibitor that targets the ATP-binding catalytic domain of ROCK1 and ROCK2. The compound exhibits an IC₅₀ of ~140 nM for ROCK1 and a Ki of 300 nM for ROCK2 under in vitro assay conditions (pH 7.4, 25°C) (APExBIO). Y-27632 shows >200-fold selectivity against related kinases, including protein kinase C (PKC), cAMP-dependent protein kinase (PKA), myosin light chain kinase (MLCK), and p21-activated kinase (PAK). Inhibition leads to suppression of Rho-mediated phosphorylation of myosin light chain (MLC), resulting in decreased actomyosin contractility and prevention of stress fiber assembly (Liu et al. 2021). These effects disrupt cell migration, reduce proliferation, and block cytokinesis in diverse cell types.

Evidence & Benchmarks

• Y-27632 inhibits ROCK1 with an IC₅₀ of approximately 140 nM and ROCK2 with a Ki of 300 nM in biochemical assays (APExBIO product sheet; link).
• At concentrations ≥10 μM, Y-27632 suppresses Rho-mediated stress fiber formation in adherent cell lines within 1 hour of treatment (Liu et al. 2021, DOI).
• Selective ROCK inhibition by Y-27632 reduces phosphorylation of myosin light chain (MLC), as confirmed by Western blot in breast cancer cell lines (Liu et al. 2021, DOI).
• In mouse models, Y-27632 administration decreases tumor invasion and metastasis, notably in spontaneous mammary tumor systems (Liu et al. 2021, DOI).
• Y-27632 is highly soluble in DMSO (≥111.2 mg/mL), ethanol (≥17.57 mg/mL), and water (≥52.9 mg/mL) at room temperature, facilitating flexible reagent preparation (APExBIO product sheet; link).
• In cell culture, addition of Y-27632 enhances survival of dissociated human pluripotent stem cells, improving colony formation rates (see G-418Sulfate.com for protocol details).

Applications, Limits & Misconceptions

Primary Applications

• Cytoskeletal studies: Used to dissect actin stress fiber dynamics and cell contractility.
• Cancer research: Employed for reducing tumor cell invasion and metastasis, especially in breast and prostate models.
• Stem cell biology: Enhances viability and expansion of human pluripotent stem cells post-dissociation (G-418Sulfate.com).
• Cell proliferation assays: Modulates cell cycle progression from G1 to S phase for mechanistic studies.
• Organoid engineering: Facilitates survival and outgrowth in organoid and tissue engineering systems (Hypoxanthine.com).

Common Pitfalls or Misconceptions

• Y-27632 is not effective against kinases outside the Rho/ROCK family at concentrations ≤100 μM; off-target inhibition is minimal in standard workflows.
• Long-term storage of Y-27632 solutions (>1 month) at room temperature leads to compound degradation; freshly prepared stocks are recommended (APExBIO).
• Not all cell types respond identically; some primary cells or lines may require titration for optimal activity.
• Y-27632 does not induce apoptosis directly but may alter survival pathways indirectly through cytoskeletal modulation.
• Inhibition of ROCK does not fully recapitulate all consequences of upstream Rho GTPase inhibition.

Compared to this article, which focuses on strategic experimental design, the present dossier provides verified, quantitative benchmarks for Y-27632 performance. The Ibupr.com review synthesizes mechanistic insight, while this piece details evidence and practical limitations for translational workflows.

Workflow Integration & Parameters

Y-27632 dihydrochloride is supplied as a solid by APExBIO (SKU: A3008) and should be stored desiccated at 4°C or below (APExBIO). For in vitro applications, dissolve in DMSO, ethanol, or water at concentrations recommended by the manufacturer (≥111.2 mg/mL in DMSO). Use warming (37°C) or ultrasonic bath for rapid solubilization. Stock solutions are stable at <-20°C for several months; avoid repeated freeze-thaw cycles. For cell-based assays, typical working concentrations range from 1 μM to 30 μM. Optimize dose and duration according to cell type and assay endpoint. For in vivo studies, consult published protocols for dosing, as pharmacokinetics and tissue penetration may vary.

Integration into stem cell workflows, tumor invasion assays, and cytoskeletal studies should be based on established benchmarks. For advanced organoid and disease modeling, reference this detailed review for strategy updates beyond standard monolayer cultures.

Conclusion & Outlook

Y-27632 dihydrochloride is a reference-standard, selective ROCK1/2 inhibitor with robust validation in cytoskeletal, stem cell, and tumor biology research. Its high selectivity, solubility, and reproducible effects make it indispensable for dissecting Rho/ROCK signaling. Ongoing research continues to expand its applications, including in organoid models and regenerative medicine. For comprehensive experimental control and translational impact, Y-27632 remains the tool of choice for targeted modulation of ROCK activity. For further product specifications, protocols, and ordering, visit the APExBIO Y-27632 dihydrochloride product page.